KOREA WHO

Seo Jung-jin is the chairman of Celltrion Group.

He is driving the transformation of Celltrion from a biosimilar company into a developer of innovative new drugs.

He was born on October 23, 1957, in Cheongju, North Chungcheong Province.

He graduated from Jemulpo High School in Incheon and earned a bachelor’s degree in industrial engineering from Konkuk University, followed by a master’s degree from the Graduate School of Industrial Engineering at Konkuk University.

In 1983, he began his career at Samsung Electro-Mechanics. He later moved to the Korea Productivity Center, where he worked as a consultant for Daewoo Motors, and was eventually appointed planning and finance advisor at Daewoo Motors.

When the Daewoo Group collapsed during the Asian financial crisis, he lost his job and, together with about ten former Daewoo Motors colleagues, founded Nexol in 1999, the predecessor of Celltrion.

In 2020, he stepped back from management after introducing a professional management system at Celltrion Group, but he returned in March 2023.

He aims to grow Celltrion into a global pharmaceutical leader with KRW 10 trillion (US$ 7.2 billion) in annual sales by 2030.

He is recognized for his sharp ability to identify core issues. When problems arise, he goes straight to the site and tackles them hands-on to find solutions.

He enjoys his work so much that he even names overseas business trips as his favorite pastime.

#Celltrion #SeoJungjin #biosimilar #biopharma #newdrugdevelopment #pharmaceutical #globalexpansion #Korea #leadership #innovation